Syros Pharmaceuticals Inc (SYRS)
5.435
-0.04
(-0.82%)
USD |
NASDAQ |
May 17, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Max Drawdown (5Y): 98.58% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.58% |
| March 31, 2024 | 98.58% |
| February 29, 2024 | 98.58% |
| January 31, 2024 | 98.58% |
| December 31, 2023 | 98.58% |
| November 30, 2023 | 98.58% |
| October 31, 2023 | 98.58% |
| September 30, 2023 | 98.32% |
| August 31, 2023 | 98.32% |
| July 31, 2023 | 98.32% |
| June 30, 2023 | 98.32% |
| May 31, 2023 | 98.32% |
| April 30, 2023 | 98.32% |
| March 31, 2023 | 98.21% |
| February 28, 2023 | 97.97% |
| January 31, 2023 | 97.97% |
| December 31, 2022 | 97.97% |
| November 30, 2022 | 97.64% |
| October 31, 2022 | 97.22% |
| September 30, 2022 | 97.08% |
| August 31, 2022 | 97.08% |
| July 31, 2022 | 97.08% |
| June 30, 2022 | 97.08% |
| May 31, 2022 | 97.08% |
| April 30, 2022 | 96.46% |
| Date | Value |
|---|---|
| March 31, 2022 | 95.71% |
| February 28, 2022 | 94.63% |
| January 31, 2022 | 92.21% |
| December 31, 2021 | 86.27% |
| November 30, 2021 | 83.87% |
| October 31, 2021 | 82.86% |
| September 30, 2021 | 82.82% |
| August 31, 2021 | 82.82% |
| July 31, 2021 | 81.22% |
| June 30, 2021 | 81.22% |
| May 31, 2021 | 81.22% |
| April 30, 2021 | 81.22% |
| March 31, 2021 | 81.22% |
| February 28, 2021 | 81.22% |
| January 31, 2021 | 81.22% |
| December 31, 2020 | 81.22% |
| November 30, 2020 | 81.22% |
| October 31, 2020 | 81.22% |
| September 30, 2020 | 81.22% |
| August 31, 2020 | 81.22% |
| July 31, 2020 | 81.22% |
| June 30, 2020 | 81.22% |
| May 31, 2020 | 81.22% |
| April 30, 2020 | 81.22% |
| March 31, 2020 | 81.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
76.80%
Minimum
May 2019
98.58%
Maximum
Oct 2023
88.60%
Average
83.37%
Median
Max Drawdown (5Y) Benchmarks
| PAVmed Inc | 98.81% |
| Moderna Inc | 85.65% |
| Altimmune Inc | 99.85% |
| iBio Inc | 99.97% |
| Lixte Biotechnology Holdings Inc | 97.86% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -62.08 |
| Beta (5Y) | 1.755 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 105.1% |
| Historical Sharpe Ratio (5Y) | -0.4046 |
| Historical Sortino (5Y) | -1.014 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.76% |